Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.05 USD | +2.09% | -9.52% | +65.40% |
05-10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
05-09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- Official Publications